Final Results from the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression

  1. Bardia, A.
  2. Rugo, H.S.
  3. Tolaney, S.M.
  4. Loirat, D.
  5. Punie, K.
  6. Oliveira, M.
  7. Brufsky, A.
  8. Kalinsky, K.
  9. Cortes, J.
  10. Shaughnessy, J.O.
  11. Dieras, V.
  12. Carey, L.A.
  13. Gianni, L.
  14. Piccart-Gebhart, M.
  15. Loibl, S.
  16. Yoon, O.K.
  17. Pan, Y.
  18. Hofsess, S.
  19. Phan, S.-C.
  20. Hurvitz, S.A.
Revista:
Journal of Clinical Oncology

ISSN: 1527-7755 0732-183X

Ano de publicación: 2024

Volume: 42

Número: 15

Páxinas: 1738-1744

Tipo: Artigo

DOI: 10.1200/JCO.23.01409 GOOGLE SCHOLAR